Company Overview
QUOIN PHARMACEUTICALS, LTD.
QNRXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-16M
2025 FY
Shares Outstanding
1M
2025 FY
EPS
-14.8USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1671502
Exchange
Nasdaq
Location
IL